In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim--nitrofurantoin combination. 1976

P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009582 Nitrofurantoin A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. Furadantin,Furadantine,Furadoine,Furadonine,Furantoin,Macrodantin,Nitrofurantoin Sodium Salt,Nitrofurantoin, Monohydrate
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004754 Enterobacter Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth
July 1979, Journal of postgraduate medicine,
P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth
January 1966, Journal of the Indian Medical Association,
P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth
January 1985, Chemotherapy,
P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth
September 1971, Schweizerische medizinische Wochenschrift,
P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth
October 1969, The Indian journal of medical research,
P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth
December 1970, Scandinavian journal of infectious diseases,
P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth
October 1994, American journal of veterinary research,
P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth
April 1983, British medical journal (Clinical research ed.),
P Anklesaria, and S Paranjpe, and K Gupta, and V Acharya, and T Paul, and U K Sheth
May 1983, British medical journal (Clinical research ed.),
Copied contents to your clipboard!